arvato services healthcare said that this new approach is based on its expertise and network and is expected to enable US and other non-European companies to furnish medical professionals and patients across Europe with quality service.
Thorsten Winkelmann, president of arvato services healthcare, said: “Bridge to Europe represents a step forward in our ability to assist US companies’ expansion into the complicated, but lucrative, European pharma market. We look forward to providing this Bridge to Europe to many more companies in the coming months.”
Christian Wolf, director of arvato services healthcare, said: “It is completely understandable why healthcare-related companies in the US and elsewhere are somewhat reluctant to expand operations in Europe. Our offering takes into account the many identified factors in those hesitations.
“Over the years, our division has evolved from a distribution entity into a powerful supply chain solutions provider that is able to partner with companies from Phase II to the commercial sale. Now with Bridge to Europe, we are supremely confident that our in-house expertise and our strong partner network position arvato services healthcare as the ideal collaborator for companies that are ready to tackle the European healthcare market.”